CAFs are the primary source of IL-6 in the tumor microenvironment of GC, and CAF-produced IL-6 activates the Jak1-STAT3 pathway in GC cells via paracrine signaling, resulting in the development of chemotherapeutic resistance. Here, IL6 is linked to neoplasm.